These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 17329095)
1. Important prognostic factors for the long-term survival of subjects with primary liver cancer in Taiwan: a hyperendemic area. Chen PH; Lin YC; Tu HP; Chiang SL; Ko AM; Hsu CL; Chang YF; Ko YC Eur J Cancer; 2007 Apr; 43(6):1076-84. PubMed ID: 17329095 [TBL] [Abstract][Full Text] [Related]
2. Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan. Chiang TA; Chen PH; Wu PF; Wang TN; Chang PY; Ko AM; Huang MS; Ko YC BMC Cancer; 2008 Nov; 8():324. PubMed ID: 18992131 [TBL] [Abstract][Full Text] [Related]
3. Important prognostic factors of long-term oropharyngeal carcinoma survivors in Taiwan. Chen PH; Ko YC; Yang YH; Lin YC; Shieh TY; Chen CH; Tsai CC Oral Oncol; 2004 Sep; 40(8):847-55. PubMed ID: 15288842 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969 [TBL] [Abstract][Full Text] [Related]
5. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Sundelöf M; Lagergren J; Ye W Eur J Cancer; 2008 Jul; 44(11):1566-71. PubMed ID: 18434132 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy. Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626 [TBL] [Abstract][Full Text] [Related]
7. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study. Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC; Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296 [TBL] [Abstract][Full Text] [Related]
9. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Pandey D; Lee KH; Wai CT; Wagholikar G; Tan KC Ann Surg Oncol; 2007 Oct; 14(10):2817-23. PubMed ID: 17690940 [TBL] [Abstract][Full Text] [Related]
10. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? Cho SJ; Yoon JH; Hwang SS; Lee HS J Gastroenterol Hepatol; 2007 Aug; 22(8):1226-31. PubMed ID: 17498220 [TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Cox's and relative survival models when estimating the effects of prognostic factors on disease-specific mortality: a simulation study under proportional excess hazards. Le Teuff G; Abrahamowicz M; Bolard P; Quantin C Stat Med; 2005 Dec; 24(24):3887-909. PubMed ID: 16320267 [TBL] [Abstract][Full Text] [Related]
13. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma. Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009 [TBL] [Abstract][Full Text] [Related]
14. Survival rate for liver cancer in Taiwan. Lee CL; Ko YC; Choong CS Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):16-20. PubMed ID: 10645046 [TBL] [Abstract][Full Text] [Related]
15. Predictors of survival after resection of early hepatocellular carcinoma. Nathan H; Schulick RD; Choti MA; Pawlik TM Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575 [TBL] [Abstract][Full Text] [Related]
17. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595 [TBL] [Abstract][Full Text] [Related]
18. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133 [TBL] [Abstract][Full Text] [Related]
19. Risk and predictors of mortality associated with chronic hepatitis B infection. Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ; Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844 [TBL] [Abstract][Full Text] [Related]
20. Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience. Jan CF; Chen CJ; Chen HH J Gastroenterol Hepatol; 2005 Apr; 20(4):521-6. PubMed ID: 15836699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]